{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T14:02:00Z","timestamp":1784988120458,"version":"3.55.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100006095","name":"South-Eastern Norway Regional Health Authority","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006095","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008730","name":"The Norwegian Cancer Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008730","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","eu-focus.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Focus"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.euf.2025.07.010","type":"journal-article","created":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T11:24:36Z","timestamp":1753701876000},"page":"915-920","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Clinical Trial Protocol for prePSMA: A Multicenter, Randomized, Noninferiority Trial of Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography\/Computed Tomography as Triage for Extended Pelvic Lymph Node Dissection in Patients Scheduled for Robot-assisted Laparoscopic Radical Prostatectomy"],"prefix":"10.1016","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7615-1695","authenticated-orcid":false,"given":"Lars F.","family":"Qvigstad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsti","family":"Aas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Tulipan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Knut H.","family":"Hole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne H.","family":"Stor\u00e5s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Hammarstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Ghiasvand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stein H.","family":"Holmedal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktor","family":"Berge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euf.2025.07.010_b0005","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ucl.2009.11.002","article-title":"Controversies surrounding lymph node dissection for prostate cancer","volume":"37","author":"Palapattu","year":"2010","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.euf.2025.07.010_b0010","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s12957-024-03344-2","article-title":"The role and controversy of pelvic lymph node dissection in prostate cancer treatment: a focused review","volume":"22","author":"Dong","year":"2024","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.euf.2025.07.010_b0015","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.eururo.2016.12.003","article-title":"The benefits and harms of different extents of lymph node dissection during radical prostatectomy for prostate cancer: a systematic review","volume":"72","author":"Fossati","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2025.07.010_b0020","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1097\/01.ju.0000143448.04161.cc","article-title":"Prognosis of patients with lymph node positive prostate cancer following radical prostatectomy: long-term results","volume":"172","author":"Daneshmand","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2025.07.010_b0025","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.eururo.2017.09.027","article-title":"Survival outcomes of men with lymph node-positive prostate cancer after radical prostatectomy: a comparative analysis of different postoperative management strategies","volume":"73","author":"Touijer","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2025.07.010_b0030","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.eururo.2020.11.040","article-title":"Extended versus limited pelvic lymph node dissection during radical prostatectomy for intermediate- and high-risk prostate cancer: early oncological outcomes from a randomized phase 3 trial","volume":"79","author":"Lestingi","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2025.07.010_b0035","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.eururo.2009.03.012","article-title":"Pelvic lymph node dissection in prostate cancer","volume":"55","author":"Briganti","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2025.07.010_b0040","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.eururo.2024.10.006","article-title":"Pelvic lymph node dissection in prostate cancer: update from a randomized clinical trial of limited versus extended dissection","volume":"87","author":"Touijer","year":"2025","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2025.07.010_b0045","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/j.1442-2042.2012.02993.x","article-title":"Lymph node count threshold for optimal pelvic lymph node staging in prostate cancer","volume":"19","author":"Abdollah","year":"2012","journal-title":"Int J Urol"},{"key":"10.1016\/j.euf.2025.07.010_b0050","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.eururo.2007.07.035","article-title":"The template of the primary lymphatic landing sites of the prostate should be revisited: results of a multimodality mapping study","volume":"53","author":"Mattei","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2025.07.010_b0055","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.eururo.2018.10.012","article-title":"A novel nomogram to identify candidates for extended pelvic lymph node dissection among patients with clinically localized prostate cancer diagnosed with magnetic resonance imaging-targeted and systematic biopsies","volume":"75","author":"Gandaglia","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2025.07.010_b0060","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/S0140-6736(20)30314-7","article-title":"Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study","volume":"395","author":"Hofman","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.euf.2025.07.010_b0065","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1001\/jamaoncol.2021.3771","article-title":"Diagnostic accuracy of 68Ga-PSMA-11 PET for pelvic nodal metastasis detection prior to radical prostatectomy and pelvic lymph node dissection: a multicenter prospective phase 3 imaging trial","volume":"7","author":"Hope","year":"2021","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.euf.2025.07.010_b0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.euo.2021.08.001","volume":"5","author":"Stabile","year":"2022","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.euf.2025.07.010_b0075","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.euo.2023.05.003","volume":"6","author":"Gandaglia","year":"2023","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.euf.2025.07.010_b0080","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.euo.2023.03.010","volume":"6","author":"Vis","year":"2023","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.euf.2025.07.010_b0085","doi-asserted-by":"crossref","first-page":"208","DOI":"10.2967\/jnumed.120.246363","article-title":"Diagnostic accuracy of 18F-PSMA-1007 PET\/CT imaging for lymph node staging of prostate carcinoma in primary and biochemical recurrence","volume":"62","author":"Sprute","year":"2021","journal-title":"J Nucl Med"},{"key":"10.1016\/j.euf.2025.07.010_b0090","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/j.euf.2021.11.003","article-title":"Clinical trial protocol for PSMA-SELECT: a Dutch national randomised study of prostate-specific membrane antigen positron emission tomography\/computed tomography as a triage tool for pelvic lymph node dissection in patients undergoing radical prostatectomy","volume":"8","author":"Soeterik","year":"2022","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.euf.2025.07.010_b0095","series-title":"EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate cancer","author":"Cornford","year":"2024"},{"key":"10.1016\/j.euf.2025.07.010_b0100","series-title":"EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate cancer","author":"Cornford","year":"2025"},{"key":"10.1016\/j.euf.2025.07.010_b0105","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.eururo.2025.03.004","article-title":"Pelvic lymph node dissection in prostate cancer: evidence and implications","volume":"87","author":"Roberts","year":"2025","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2025.07.010_b0110","doi-asserted-by":"crossref","first-page":"E87","DOI":"10.1111\/bju.13903","article-title":"Unification of favourable intermediate-, unfavourable intermediate-, and very high-risk stratification criteria for prostate cancer","volume":"120","author":"Zumsteg","year":"2017","journal-title":"BJU Int"},{"key":"10.1016\/j.euf.2025.07.010_b0115","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1148\/radiol.210875","article-title":"Local extent of prostate cancer at MRI versus prostatectomy histopathology: associations with long-term oncologic outcomes","volume":"302","author":"Wibmer","year":"2022","journal-title":"Radiology"},{"key":"10.1016\/j.euf.2025.07.010_b0120","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.eururo.2023.02.002","article-title":"Second version of the Prostate Cancer Molecular Imaging Standardized Evaluation framework including response evaluation for clinical trials (PROMISE V2)","volume":"83","author":"Seifert","year":"2023","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2025.07.010_b0125","doi-asserted-by":"crossref","first-page":"4483","DOI":"10.1007\/s00259-021-05424-x","article-title":"Focal unspecific bone uptake on [18F]-PSMA-1007 PET: a multicenter retrospective evaluation of the distribution, frequency, and quantitative parameters of a potential pitfall in prostate cancer imaging","volume":"48","author":"Gr\u00fcnig","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.euf.2025.07.010_b0130","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00428-019-02574-0","article-title":"Dataset for the reporting of prostate carcinoma in radical prostatectomy specimens: updated recommendations from the International Collaboration on Cancer Reporting","volume":"475","author":"Kench","year":"2019","journal-title":"Virchows Arch"},{"key":"10.1016\/j.euf.2025.07.010_b0135","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1080\/21681805.2021.1946135","article-title":"Robotic salvage pelvic lymph node dissection for locoregional recurrence after radical prostatectomy: a single institution experience","volume":"55","author":"Hopland","year":"2021","journal-title":"Scand J Urol"},{"key":"10.1016\/j.euf.2025.07.010_b0140","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1097\/JU.0000000000001596","volume":"205","author":"Amiel","year":"2021","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2025.07.010_b0145","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1007\/s00345-017-2079-4","article-title":"Long-term oncological outcomes in patients with limited nodal disease undergoing radical prostatectomy and pelvic lymph node dissection without adjuvant treatment","volume":"35","author":"Mandel","year":"2017","journal-title":"World J Urol"},{"key":"10.1016\/j.euf.2025.07.010_b0150","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/j.juro.2013.11.029","article-title":"Removal of limited nodal disease in patients undergoing radical prostatectomy: long-term results confirm a chance for cure","volume":"191","author":"Seiler","year":"2014","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2025.07.010_b0155","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.eururo.2008.09.043","volume":"55","author":"Briganti","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2025.07.010_b0160","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.juro.2007.05.048","article-title":"Long-term outcome after radical prostatectomy for patients with lymph node positive prostate cancer in the prostate specific antigen era","volume":"178","author":"Boorjian","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2025.07.010_b0165","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.eururo.2024.12.001","article-title":"Oncological benefits of extended pelvic lymph node dissection: more fog or clarity to the debate?","volume":"87","author":"Roberts","year":"2025","journal-title":"Eur Urol"}],"container-title":["European Urology Focus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405456925002135?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405456925002135?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T18:14:26Z","timestamp":1772907266000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405456925002135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S2405456925002135"],"URL":"https:\/\/doi.org\/10.1016\/j.euf.2025.07.010","relation":{},"ISSN":["2405-4569"],"issn-type":[{"value":"2405-4569","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical Trial Protocol for prePSMA: A Multicenter, Randomized, Noninferiority Trial of Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography\/Computed Tomography as Triage for Extended Pelvic Lymph Node Dissection in Patients Scheduled for Robot-assisted Laparoscopic Radical Prostatectomy","name":"articletitle","label":"Article Title"},{"value":"European Urology Focus","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euf.2025.07.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 European Association of Urology. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}